Edition:
United Kingdom

Income Statements: Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

81.50USD
5:54pm BST
Change (% chg)

$0.48 (+0.59%)
Prev Close
$81.02
Open
$81.39
Day's High
$81.93
Day's Low
$81.12
Volume
678,461
Avg. Vol
3,412,317
52-wk High
$83.81
52-wk Low
$58.03

Interim Income Statement
View: AnnualInterim

In Millions ofU.S. Dollars
(except for per share items)
2019
2019-03-31
Period Length
3 Months
Revenue 10,816.0
Other Revenue, Total --
Total Revenue 10,816.0
Cost of Revenue, Total 3,018.0
Gross Profit 7,798.0
Selling/General/Admin. Expenses, Total 2,425.0
Research & Development 1,931.0
Depreciation/Amortization --
Interest Expense, Net - Operating --
Interest/Investment Income - Operating --
Interest Expense(Income) - Net Operating --
Unusual Expense (Income) 187.0
Other Operating Expenses, Total --
Total Operating Expense 7,561.0
Operating Income 3,255.0
Interest Expense, Net Non-Operating (209.0)
Interest/Invest Income - Non-Operating (37.0)
Interest Income(Exp), Net Non-Operating --
Gain (Loss) on Sale of Assets --
Other, Net 58.0
Net Income Before Taxes 3,067.0
Provision for Income Taxes 205.0
Net Income After Taxes 2,862.0
Minority Interest 53.0
Equity In Affiliates --
U.S. GAAP Adjustment --
Net Income Before Extra. Items 2,915.0
Accounting Change --
Discontinued Operations --
Extraordinary Item --
Tax on Extraordinary Items --
Net Income 2,915.0
Preferred Dividends --
General Partners' Distributions --
Miscellaneous Earnings Adjustment --
Pro Forma Adjustment --
Interest Adjustment - Primary EPS --
Income Available to Com Excl ExtraOrd 2,915.0
Income Available to Com Incl ExtraOrd 2,915.0
Basic Weighted Average Shares 2,585.00
Basic EPS Excluding Extraordinary Items 1.128
Basic EPS Including Extraordinary Items 1.128
Dilution Adjustment --
Diluted Weighted Average Shares 2,603.00
Diluted EPS Excluding ExtraOrd Items 1.120
Diluted EPS Including ExtraOrd Items 1.120
DPS - Common Stock Primary Issue 0.550
Gross Dividends - Common Stock 1,429.0
Total Special Items 735.0
Normalized Income Before Taxes 3,802.0
Effect of Special Items on Income Taxes (205.0)
Inc Tax Ex Impact of Sp Items 0.0
Normalized Income After Taxes 3,802.0
Normalized Inc. Avail to Com. 3,855.0
Basic Normalized EPS 1.491
Diluted Normalized EPS 1.481

Congo wants more use of Merck vaccine rather than J&J newcomer - minister

GENEVA, May 22 Democratic Republic of Congo called on Wednesday for Merck's experimental Ebola vaccine to be fully licensed to facilitate its use in the Ebola-hit country, while saying Johnson & Johnson's rival drug would complicate matters.